SEGMENT INFORMATION (Tables)

12 Months Ended

Mar. 30, 2013

Segment Reporting [Abstract]

Schedule of Revenues from External Customers

Revenues from External Customers:

(In thousands)	March 30, 2013		March 31, 2012		April 2, 2011
Disposable revenues
Plasma disposables	$	268,900	$	258,061	$	227,209
Blood center disposables
Platelet	169,602		167,946		156,251
Red cell	49,733		48,034		46,828
Whole blood	138,436		—		—
	357,771		215,980		203,079
Hospital disposables
Surgical	73,508		66,619		66,503
OrthoPAT	30,230		31,186		35,631
Diagnostics	27,356		23,087		19,414
	131,094		120,892		121,548
Disposables revenue	757,765		594,933		551,836
Software solutions	69,952		70,557		66,876
Equipment & other	64,273		62,354		57,982
Total revenues	$	891,990	$	727,844	$	676,694

Enterprise Wide Disclosures about Product and Services

Enterprise Wide Disclosures About Product and Services

Year Ended (in thousands)

March 30, 2013	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	454,874	$	6,851	$	461,725	$	120,726	$	84,860	$	224,679	$	891,990
Total Assets	$	830,754	$	225,849	$	1,056,603	$	44,189	$	41,037	$	320,088	$	1,461,917
Long-Lived Assets	$	503,606	$	209,439	$	713,045	$	12,977	$	8,076	$	117,717	$	851,815

March 31, 2012	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	352,160	$	512	$	352,672	$	124,381	$	67,223	$	183,568	$	727,844
Total Assets	$	634,171	$	15,365	$	649,536	$	50,509	$	27,353	$	183,737	$	911,135
Long-Lived Assets	$	305,370	$	12,796	$	318,166	$	13,128	$	3,961	$	38,009	$	373,264

April 2, 2011	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	316,447	$	908	$	317,355	$	110,263	$	61,594	$	187,482	$	676,694
Total Assets	$	582,733	$	15,903	$	598,636	$	47,156	$	18,164	$	169,308	$	833,264
Long-Lived Assets	$	305,305	$	12,715	$	318,020	$	12,391	$	4,181	$	38,092	$	372,684